PATENT CLAIM ANALYSIS

Application Number: 15576927
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "303000"]

Abstract:
The present invention provides a method for treating or preventing a renal injury-related disease such as diabetic nephropathy comprising administering to a mammal a therapeutically effective amount of 2-({[ 7 -hydroxy-5-(2-phenylethyl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]carbonyl}amino)acetic acid or a pharmaceutically acceptable salt thereof, and a novel pharmaceutical use of the aforementioned compound such as a pharmaceutical composition for treating or preventing a renal injury-related disease and the like comprising the aforementioned compound or a pharmaceutically acceptable salt thereof.

Claim (Index 5):
The method according to  claim 3 , wherein the chronic kidney disease caused by hypoxia is a chronic kidney disease associated with hypertension.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 93.0
- Lexical Diversity: 1.62712
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13979127', '15704713', '14117728', '15523512', '15117233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683806322725322
- 35 USC 102 Novelty (BERT): 0.5175876639325113
- Combined Prediction Score: 0.7433013354385302
- Mean Citation Score: 301.35526600000014
- Max Citation Score: 317.56458
- Similarity Product: 258.9934556831217

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test